Abstract
Introduction
The calcium-sensing receptor (CaR), a G proteincoupled receptor that signals through G␣i, G␣q and sometimes G␣12/13 pathways, is best known and understood for its role in regulating the secretion and synthesis of parathyroid hormone in response to extracellular Ca in the parathyroid glands [1] [3] [4] [5] [6] . Additionally, its biologic effects in tissues such as the kidney or parathyroid glands cannot be explained completely on the basis of known second messenger signalling effects [1, 7] . [8] [9] [10] [11] (Fig. 1) [9] [10] [11] .
The original model of signalling by G proteindependent receptors was relatively simple. The receptors and G proteins through which the intracellular second messenger systems are activated are attached to the plasma membrane of the cell. These proteins could be relatively free in the membrane or loosely associated with each other. Upon activation of a receptor, the protein interactions change, G proteins are activated, which in turn activate effector molecules such as enzymes or ion channels, to generate intracellular signals (Fig. 1). As techniques to identify protein-protein interactions have been developed and as more precise analysis of cell signalling has become possible, the inadequacy of the original model has become clear through demonstration that G protein-coupled receptors interact with many intracellular proteins in addition to G proteins. These interacting proteins include RGS proteins (Regulator of G protein Signalling), scaffolding and structural proteins, ion channels, additional signalling proteins, chaperone and trafficking proteins and others that may not have defined functions yet

Signalling by the CaR
Most work on the signalling pathways controlled by the CaR has focused on traditional G protein-coupled pathways, G␣i, G␣q, and in some cases G␣12 or G␣13 [1, [12] [13] [14] [15] [16] (Fig. 2) [18] . In keeping with studies of other G protein-coupled receptors, the CaR transactivates, the epidermal growth factor receptor presumably via a matrix metalloproteinase [19, 20] [35] .
RAMPS (Receptor Activity Modifying Proteins)
The CaR, a class 3 G protein-coupled receptor, interacts with RAMP1 and RAMP3 [37] . [9, 35] . [11, 42] . [42, 43] [44, 45] . [46] [47] [48] [40, 41, 50] . This interaction is also important for CaR-mediated Rho activation because expression of peptides that interfere with the CaR-filamin interaction block CaRmediated Rho activation [15] . The simplest explanation for these observations is that filamin contributes to cell surface expression of the CaR. This is certainly the case, but even in the absence of filamin some CaR reaches the cell surface [51] . [12] . Ca [12, 52] . [84] . Filamin may also contribute to these interactions [82] . The CaR coimmunoprecipitates with PI-4-kinase and rho and stimulates PI-4-kinase activity [71] . This arrangement of proteins could result in a signalling module that regulates the metabolism of inositol lipids in a coordinated manner and in a limited region of the cell to precisely control processes such as channel activity, or it could contribute to protein trafficking that can also depend on inositol lipid metabolism [9, 54, 69] . [16, 71] . 
The initial observation was that the CaR could not reach the cell surface in COS7 cells. Subsequently, the investigators found that COS7 cells do not express any of the known RAMPs. Interaction of the CaR with one of these RAMPS is required for cell surface expression. In the absence of RAMP1 or 2, the CaR is trapped in the endoplasmic reticulum in an immature core glycoslyated form. The RAMPs facilitate its exit from the endoplasmic reticulum, and its transit to the Golgi where it is glycosylated and then moves to the cell surface. The functional consequences of interaction with RAMP1 or RAMP3 were not tested, so it is possible that interaction with the two different RAMPs leads to different CaR activation kinetics. The fact that RAMP3 has a C-terminal PDZ domain means that it could also contribute to localization of the CaR in the cell and with other signalling proteins. For example, RAMP-3 interacts with N-ethylmaleimidesensitive factor (NSF) via its PDZ domain. Interaction with NSF is required for recycling of the agonistoccupied CLR and ␤2-adrenergic receptor
Filamin
At least two groups identified filamin as a CaR interacting protein that could serve as a scaffold for other signalling proteins [40, 41]. Filamin is a homodimer made up of 280 kD proteins that contain N-terminal actin-binding domains, 24 96 AA IgG-like repeats, a C-terminal dimerization domain (repeat 24) and two hinge regions [42, 43]. Filamin was originally described as an actin cross-linking protein that provides mechanical strength to the actin cytoskeleton. Subsequently, it was found to interact with a number of TM proteins (many of them signalling proteins) and anchor them and the plasma membrane to the cytoskeleton. A partial list of these proteins includes ␤ integrins, Ca and K channels, a subset of G protein-coupled receptors (the D2 dopamine receptor, the CTR, some metabotropic glutamate receptors, and the CaR), and the insulin receptor
Filamin also interacts with intracellular signalling proteins including MAP kinases, Rho GTPases, Rho guanine nucleotide exchange factors (GEFs), Rho kinase, SMADS and phosphatases
. Filamin appears to be involved in organization of these proteins in the cell and in their trafficking in that under the correct experimental conditions, loss of filamin or interference with its interaction with the protein of interest results in altered membrane expression and lost or reduced function
A problem in understanding the function of filamin is that its distribution in various differentiated cells has not been fully determined. Despite the fact that filamin is generally considered a cytoskeletal protein, most of it is found in the soluble fraction of hepatocytes, endothelial cells and presumably other cell types
Evidence that filamin also provides an important scaffolding function comes from studies of Ca or Phe-induced CaR-mediated intracellular Ca oscillations
Although the precise mechanism by which filamin is involved in CaR-mediated inhibition of parathyroid hormone secretion on the apical surface of parathyroid cells is not defined, an intact cytoskeleton is required [53]. If filamin is primarily found on the apical surface of epithelial cells, its interaction with the CaR may be important for those cell types (e.g. renal proximal tubule, intestinal and parathyroid cells) where the CaR is expressed on the apical surface. Other interacting proteins may contribute to its function in other cell locations.
Potassium channels
Regulators of G protein signalling (RGS) proteins have been implicated in CaR signalling through expression studies, but interactions of the CaR or a CaR-based signalling complex with specific RGS proteins have not been demonstrated
Conclusions
